FR2110458A1 - - Google Patents

Info

Publication number
FR2110458A1
FR2110458A1 FR7137143A FR7137143A FR2110458A1 FR 2110458 A1 FR2110458 A1 FR 2110458A1 FR 7137143 A FR7137143 A FR 7137143A FR 7137143 A FR7137143 A FR 7137143A FR 2110458 A1 FR2110458 A1 FR 2110458A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7137143A
Other languages
French (fr)
Other versions
FR2110458B1 (OSRAM
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
HOWARD ALAN GB
Original Assignee
HOWARD ALAN GB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by HOWARD ALAN GB filed Critical HOWARD ALAN GB
Publication of FR2110458A1 publication Critical patent/FR2110458A1/fr
Application granted granted Critical
Publication of FR2110458B1 publication Critical patent/FR2110458B1/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR7137143A 1970-10-15 1971-10-15 Expired FR2110458B1 (OSRAM)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB4914070 1970-10-15

Publications (2)

Publication Number Publication Date
FR2110458A1 true FR2110458A1 (OSRAM) 1972-06-02
FR2110458B1 FR2110458B1 (OSRAM) 1975-02-07

Family

ID=10451313

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7137143A Expired FR2110458B1 (OSRAM) 1970-10-15 1971-10-15

Country Status (7)

Country Link
US (1) US3846541A (OSRAM)
AU (1) AU458705B2 (OSRAM)
CA (1) CA968272A (OSRAM)
DE (1) DE2151510A1 (OSRAM)
FR (1) FR2110458B1 (OSRAM)
GB (1) GB1348642A (OSRAM)
SE (1) SE402709B (OSRAM)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0225615A3 (en) * 1985-12-09 1988-04-20 Ciba-Geigy Ag Resinate sustained release dextromethorphan composition
EP0282453A1 (de) * 1987-03-10 1988-09-14 Ciba-Geigy Ag Hypocholesterinämische Gelformulierung auf Anionenaustauscherharz-Basis
WO1991003249A1 (de) * 1989-09-09 1991-03-21 Knoll Aktiengesellschaft Colestyramin als lipidsenker enthaltende präparate

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4069306A (en) * 1974-03-14 1978-01-17 Pharmacia Aktiebolag X-ray contrast preparation containing a hydrophilic polymer containing amino groups
FR2382892A1 (fr) * 1977-03-08 1978-10-06 Sarget Lab Nouveau medicament hypolipidemiant a base d'ester de p-chlorophenol de l'acide p-chlorophenoxyisobutyrique
IT1106718B (it) * 1978-12-21 1985-11-18 Alfa Farmaceutici Spa Composizioni a base di resine anioniche salificate farmacologicamente attive
US4393145A (en) * 1979-05-01 1983-07-12 Etablissement Texcontor Anionic ion exchange resins with cholesterol-decreasing properties
EP0276807A3 (en) * 1987-01-27 1988-10-12 Warner-Lambert Company Lipid regulating compositions
US5167965A (en) * 1987-02-09 1992-12-01 The Dow Chemical Company Palatable cholestyramine granules, tablets and methods for preparation thereof
US4837255A (en) * 1987-03-10 1989-06-06 Ciba-Geigy Corporation Palatable hypocholesterolaemic gel formulation containing a pharmaceutically acceptable non-digestible anion exchange resin
US4859703A (en) * 1987-06-15 1989-08-22 Warner-Lambert Company Lipid regulating compositions
US5520932A (en) * 1988-06-24 1996-05-28 The Upjohn Company Fine-milled colestipol hydrochloride
US20050090553A1 (en) * 1992-06-30 2005-04-28 Shapiro Howard K. Compositions and method for treatment of chronic inflammatory diseases
US8178516B2 (en) * 1992-06-30 2012-05-15 Sylvan Labs, LLC Compositions and method for treatment of chronic inflammatory diseases
US5498678A (en) * 1992-12-21 1996-03-12 Rohm And Haas Company Suspension polymerization process for water-soluble monomers
US5451397A (en) * 1992-12-21 1995-09-19 Rohm And Haas Company Bile acid sequestrant
US7071174B1 (en) * 1994-10-13 2006-07-04 Cv Therapeutics, Inc. Method and composition for inhibiting cholesterol esterase
LT2637668T (lt) 2010-11-04 2016-09-12 Albireo Ab Ibat inhibitoriai kepenų ligoms gydyti
PL2637646T3 (pl) 2010-11-08 2017-01-31 Albireo Ab Kombinacja farmaceutyczna zawierająca inhibitor ibat i środek wiążący kwasy żółciowe
CA2842802C (en) * 2011-08-01 2020-03-10 Hb Biotechnologies Corporation Non-digestible capsules for the delivery of fluid absorbing materials
KR20190135545A (ko) 2011-10-28 2019-12-06 루메나 파마수티컬즈, 인코포레이티드 고담혈증 및 담즙 정체성 간 질환 치료용 담즙산 재순환 억제제
EP2771003B1 (en) 2011-10-28 2017-04-19 Lumena Pharmaceuticals LLC Bile acid recycling inhibitors for treatment of pediatric cholestatic liver diseases
CN105228615A (zh) 2013-03-15 2016-01-06 鲁美纳医药公司 用于治疗巴雷特食管和胃食管返流疾病的胆汁酸再循环抑制剂
WO2014144650A2 (en) 2013-03-15 2014-09-18 Lumena Pharmaceuticals, Inc. Bile acid recycling inhibitors for treatment of primary sclerosing cholangitis and inflammatory bowel disease
JP7562546B2 (ja) 2019-02-12 2024-10-07 ミルム ファーマシューティカルズ インコーポレイテッド 胆汁うっ滞性肝疾患を有する小児対象の成長を増加させる方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB860303A (en) * 1958-06-20 1961-02-01 Ici Ltd Pharmaceutical compositions comprising ª‡-aryloxy-aliphatic carboxylic acids and/or ª
US3042667A (en) * 1959-03-10 1962-07-03 Pharmacia Ab Process for producing dextran derivatives and products resulting therefrom
NL126243C (OSRAM) * 1959-06-12
US3383281A (en) * 1961-09-22 1968-05-14 Merck & Co Inc Method for binding bile acids in vivo
US3308020A (en) * 1961-09-22 1967-03-07 Merck & Co Inc Compositions and method for binding bile acids in vivo including hypocholesteremics
US3627872A (en) * 1968-04-08 1971-12-14 Upjohn Co Oral treatment of hyper-cholesteremia in mammals and birds with ether-type anion exchangers of polysaccharides

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0225615A3 (en) * 1985-12-09 1988-04-20 Ciba-Geigy Ag Resinate sustained release dextromethorphan composition
EP0282453A1 (de) * 1987-03-10 1988-09-14 Ciba-Geigy Ag Hypocholesterinämische Gelformulierung auf Anionenaustauscherharz-Basis
WO1991003249A1 (de) * 1989-09-09 1991-03-21 Knoll Aktiengesellschaft Colestyramin als lipidsenker enthaltende präparate

Also Published As

Publication number Publication date
FR2110458B1 (OSRAM) 1975-02-07
DE2151510A1 (de) 1972-04-20
AU458705B2 (en) 1975-03-06
AU3451371A (en) 1973-04-19
GB1348642A (en) 1974-03-20
CA968272A (en) 1975-05-27
US3846541A (en) 1974-11-05
SE402709B (sv) 1978-07-17

Similar Documents

Publication Publication Date Title
ATA96471A (OSRAM)
AU1473870A (OSRAM)
AU1146470A (OSRAM)
AU451388B2 (OSRAM)
AU1833270A (OSRAM)
AU2017870A (OSRAM)
AU1326870A (OSRAM)
AU1716970A (OSRAM)
AU1517670A (OSRAM)
AU2085370A (OSRAM)
AU2130570A (OSRAM)
AU1336970A (OSRAM)
AR195465A1 (OSRAM)
AU1581370A (OSRAM)
AU2061170A (OSRAM)
AU2144270A (OSRAM)
AU1247570A (OSRAM)
AU1328670A (OSRAM)
AU1235770A (OSRAM)
AU1343870A (OSRAM)
AU1189670A (OSRAM)
AU2131570A (OSRAM)
AU2130770A (OSRAM)
AU2119370A (OSRAM)
AU1591370A (OSRAM)

Legal Events

Date Code Title Description
TP Transmission of property
ST Notification of lapse